JAC Advance Access originally published online on March 13, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 51, 1001-1005
© 2003 The British Society for Antimicrobial Chemotherapy
Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals
Área de Bioquímica y Biología Molecular, Universidad de La Rioja, Madre de Dios 51, 26006, Logroño, Spain
Received 8 April 2002; returned 24 July 2002; accepted 20 January 2003
Mutations in quinolone targets were analysed in 80 unrelated nalidixic acid-resistant (NALR) Escherichia coli strains whose nalidixic acid and ciprofloxacin MICs ranged from 32 to >256 mg/L and 0.03–64 mg/L, respectively. These strains were isolated from food products (23) and faecal samples from humans (15) and healthy animals (42). Thirteen nalidixic acid-susceptible (NALS) E. coli strains were also analysed. Mutations in gyrA and parC genes were studied by PCR and sequencing. No amino acid changes were detected in GyrA or ParC proteins of the 13 NALS strains. A single change in the GyrA protein was detected in all 61 NALR strains with ciprofloxacin MICs 
2 mg/L with the following substitutions (number of strains): Ser-83
Leu (54), Ser-83Ala (one), Ser-83Val (one), Asp-87Asn (two), Asp-87Tyr (two) and Asp-87Gly (one). A double change in GyrA was found in 18 of 19 NALR strains with ciprofloxacin MICs 
4 mg/L. Amino acid substitutions were Ser-83Leu, with an additional change [Asp-87Asn (15), Asp-87Tyr (two) or Asp-87His (one)]. The remaining strain (ciprofloxacin MIC 4 mg/L) showed a single Ser-83Leu substitution. In respect of the ParC protein, a single change at Ser-80 or Glu-84 was found in 25 of 42 strains, with ciprofloxacin MICs ranging from 0.5 to 32 mg/L. A double substitution (Ser-80Ile and Glu-84Gly) was found in one strain (ciprofloxacin MIC 64 mg/L). No amino acid changes were detected in the GyrB protein of 18 NALR strains.
Keywords: Escherichia coli, quinolone resistance
* Corresponding author. Tel: +34-941-299750; Fax: +34-941-299721; E-mail: carmen.torres{at}daa.unirioja.es
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. C. Valentine, D. Contreras, S. Tan, L. J. Real, S. Chu, and H. H. Xu Phenotypic and Molecular Characterization of Acinetobacter baumannii Clinical Isolates from Nosocomial Outbreaks in Los Angeles County, California J. Clin. Microbiol., August 1, 2008; 46(8): 2499 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jurado, J. A. Orden, P. Horcajo, R. De La Fuente, J. A. Ruiz-Santa-Quiteria, S. Martinez-Pulgarin, and G. Dominguez-Bernal Characterization of fluoroquinolone resistance in Escherichia coli strains from ruminants J Vet Diagn Invest, May 1, 2008; 20(3): 342 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Maeda, A. Kiba, K. Ohnishi, and Y. Hikichi Amino Acid Substitutions in GyrA of Burkholderia glumae Are Implicated in Not Only Oxolinic Acid Resistance but Also Fitness on Rice Plants Appl. Envir. Microbiol., February 15, 2007; 73(4): 1114 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Y. Han and R. A. Andrade Brevundimonas diminuta infections and its resistance to fluoroquinolones J. Antimicrob. Chemother., June 1, 2005; 55(6): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Saenz, L. Brinas, E. Dominguez, J. Ruiz, M. Zarazaga, J. Vila, and C. Torres Mechanisms of Resistance in Multiple-Antibiotic-Resistant Escherichia coli Strains of Human, Animal, and Food Origins Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3996 - 4001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Saenz, J. Ruiz, M. Zarazaga, M. Teixido, C. Torres, and J. Vila Effect of the efflux pump inhibitor Phe-Arg-{beta}-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin J. Antimicrob. Chemother., March 1, 2004; 53(3): 544 - 545. [Full Text] [PDF]
|
|